FrieslandCampina says infant formula with premium, multi-benefit ingredients and easy-to-consume supplements for children are continued avenues for growth in Asia.
Infant formula that mimics lipid structure of breast milk enhances calcium absorption and modulates gut microbiota, and in the process, strengthens the overall immunity, say preliminary findings of an ongoing trial.
Formula giant Feihe’s half-year profit for FY24 is up 18.1 per cent on the back of increased marketing activities which is said to have acquired over 1.4 million new customers.
Danone is doubling down on its specialised nutrition offerings, including infant formula and Foods for Special Medical Purposes (FSMP) for China, a market which it said has delivered “stellar performance” for the first half of 2024.
Hydrolysed milk formula may prevent certain allergies but increase risk of wheeze as compared to breast milk, according to a new meta-analysis funded by Huhhot Science & Technology Plan and the National Center of Technology Innovation for Dairy in...
A proposal by Feihe Dairy’s chairman to add a new functional foods category to China’s regulatory system could offer financial and innovation benefits to brands, but there are concerns around its practicality and industry compliance.
Swisse’s parent company Health and Happiness Group (H&H Group) is seeing strong demand for its adult nutrition products in China, where the company has reported 12.3 per cent year-on-year (yoy) growth in Q1.
Else Nutrition, which specialises in plant-based but soy-free infant and toddler formulas, has launched in Asia-Pacific with Australia as its first stop.
Infant nutrition will take centre stage for the first session of our Growth Asia Summit 2024, with industry experts from Danone and Junlebao, and pioneering academics, sharing their latest insights into this key industry, and public health, topic.
Several major infant formula brands, including a2 milk and Danone’s Aptamil, are successfully gaining market share despite a shrinking birth rate and tighter regulatory regime in China, their latest financial results have shown.
China’s infant formula giant Feihe says group profit was down 33.5 per cent in FY23, as the country struggles with raising its birth rate despite introducing a three-child policy three years ago.
Danone’s CEO says that its business in China has been “extremely strong” in FY23 with growth propelled by its specialised nutrition portfolio, which consists of infant and medical nutrition products.
The a2 milk Company says its infant formula sales in China had increased by 1.5 per cent in the first half of FY2024, although the market had shrunk almost 14 per cent in sales.
Nicotinamide mononucleotide (NMN) is known for its longevity-related health claims, but a new observational study from Meiji claims that a higher concentration of the NMN in breast milk is linked to significantly better motor and communication skills...
Australian infant and adult milk formula firm Nutura Organic will be making its debut in Thailand through a distribution deal with major Thai food producer CP Foods.
Infants who were fed on a novel milk formula containing large milk phospholipids coated droplets in the first four months of life were found to have a body mass index (BMI) and blood pressure that were similar to breastfed infants, according to a five-year...
Demand for paediatric probiotics and nutritional supplements in mainland China declined in Q3, as parents were shopping less in pharmacies for immunity related products, according to Hong Kong-headquartered Health and Happiness Group (H&H Group).
China dairy giant Junlebao believes that the concentration of a specific variant of DHA molecules – the sn-2 DHA – plays a crucial role in the absorption and efficacy of infant formulas, and has called for industry collaboration to increase understanding...
Human milk oligosaccharides (HMOs) are now officially permitted for use in China’s infant formula, with two multinationals, namely IFF and dsm-firmenich, as well as local dairy giant Mengniu, announcing that they have received approvals in the past week.
Chinese authorities are imposing stricter rules on the infant formula industry, with terms such as “imported raw ingredients” and “imported milk source” banned on all product labelling from October 1, 2023.
To keep pace with the changing needs of consumers, the Vietnamese dairy company has secured the expertise of ingredient suppliers including DSM, Beneo and Chr. Hansen as it seeks to bring ‘milk powder closer to the golden standard of breast milk’.
In our monthly nutra regulatory round-up, we take a closer look at India’s requirements for vegan products and the special enforcement drive on non-compliant nutraceuticals, South Korea’s crackdown on fake health functional foods, and the impact of China’s...
New Zealand’s market for pea protein will grow 10-fold in the next decade, with key sectors being sports nutrition, infant formula, and plant-based dairy and meat alternatives, according to a report from trade officials.
Australian plant-based formula firm Sprout Organic is debuting its global expansion in Saudi Arabia and Malaysia, and eyes growth opportunity of dairy-free infant formula market in Asia-Pacific (APAC).
Taiwan’s Ministry of Health and Welfare (MOHW) has made it mandatory for infant and follow-up formula sold in the market to be printed with a new logo from January 2025.
Kirin’s first human milk oligosaccharides (HMOs) production plant has commenced operation and the company anticipates that half of the market will be dominated by China in the future.
Two products made from Australian and New Zealand-listed The a2 Milk Company (The a2MC) were granted entry into the US market under an expedited process, the US FDA announced.
Key players in China’s infant formula industry have reported a drop in their gross profit margins in the first six months of this year, including the biggest local player Feihe, as well as Health and Happiness Group (H&H Group), and Ausnutria.
The CEO of infant formula maker Bubs Australia says that the market dynamics in the US has given the firm the confidence that it will become as significant as China.
Australia’s plant-based infant formula brand Sprout Organic aims to introduce new packaging sizes and widen its offerings in the infant formula and supplementary food categories for young children, according to its founder and CEO Selasi Berdie.
The US Food and Drug Administration (USFDA) has refuted claims that it would be postponing all infant formula import applications under its expedited scheme.
This round-up will look at developments of brands in the health and nutrition industry, including how brands such as Bubs Australia and Bellamy’s Organic have successfully gained access to the infant formula market in US, as well as Nestle Health Science’s...
Bubs Australia’s infant formula sold in the US will receive tariff concessions under a trade deal, while the firm has also announced agreements with two additional retail groups to sell its products.
Danone New Zealand and Australia-based Bellamy’s Organic are the latest to receive the US FDA’s approval to supply infant formula to the country amid its shortage crisis.
Australia’s and New Zealand’s infant formula makers have been “encouraged” by the recent success of local brand Bubs’ entry into the US amid the shortage crisis in the country, with a number now examining export opportunities.
Here we reveal new scientific findings on how turmeric supplementation could improve metabolic parameters in patients with nonalcoholic fatty liver disease (NAFLD), Indian experts’ recommendation of Lactobacillus GG (LGG) for treating diarrhoea in children,...
Meiji is expanding its infant formulas offerings in Cambodia as part of the company’s strategy in growing its overseas business – where South East Asia is identified as a region for new opportunities.
Future infant nutrition research should look into the link between nutrients and gut-brain axis and even its impacts decades later when a child reaches adulthood, instead of merely mimicking human breast milk and focusing on only height and weight gain.
China’s food regulator is seeking public consultation on the use of the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) in infant formula as well as in foods for toddlers and young children.
This round-up will look at trends around omnichannel strategies that health supplement brands and retailers have adopted, market opportunities for enzymes, cordyceps supplements, and the infant formula market in South Korea.
The Australian company behind the plant-based infant formula Sprout Organic has entered domestic pharmacy retailer Wholelife, and now has its sights on international expansion spanning New Zealand, Asia, Europe and the US.
Online purchase of dietary supplements flourished amid the ongoing COVID-19 pandemic, but how can brands find synergies and success in the ‘best-of-worlds’ digital and brick-and-mortar retail approach? We speak to a raft of experts to find out…
A novel infant formula which is not yet commercialised has shown to promote growth comparable to standard products, according to a clinical trial funded by Danone.
More than half of parents and pregnant women (51%) surveyed for a new WHO/UNICEF report say they have been targeted with marketing from formula milk companies, much of which is in breach of international standards on infant feeding practices.
The FDA, along with CDC and state and local partners are investigating four consumer complaints of infant illness related to products from Abbott Nutrition’s Sturgis, MI facility received from 9/20/2021 to 1/11/2022.
